Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Shawn Aaron, MD
Woman and Man Max 99 years
Shawn Aaron, MD
Update Il y a 4 ans
Strategies to Improve Asthma and Treatment of Asthma in Canadians
Our study will enroll 644 randomly-selected Canadians who have been diagnosed with asthma by a physician within the previous five years. It will be determined what diagnostic tests were in...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shawn Aaron, MD
Update Il y a 5 ans
Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis
The purpose of this study is to determine the effect of AZD1236 in patients with cystic fibrosis (CF) on inflammatory biomarkers in induced sputum, after a treatment period of 4 weeks.
Country
Canada
,
Netherlands
,
Poland
,
Spain
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shawn Aaron, MD FRCPC
Update Il y a 4 ans
Evaluation of a Decision Aid for Adult Cystic Fibrosis Patients Considering Bilateral Lung Transplantation
In 2006, the International Patient Decision Aids Collaboration (IPDAS) reached agreement on criteria for evaluation. Accordingly, the primary outcome is 'decision quality' 3 weeks after us...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shawn Aaron, MD
Update Il y a 5 ans
Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis
This clinical trial will attempt to determine whether we can improve clinical outcomes for patients with cystic fibrosis who are infected with a fungus called Aspergillus fumigatus.
Country
Canada
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shawn Aaron, MD, MSc
Update Il y a 4 ans
TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
The purpose of this study is to determine whether treatment with antibiotics plus a TNFalpha antagonist will provide more effective treatment for acute COPD exacerbation compared to the cu...
Country
None
organs
None
Specialty
None
Closed trial
More information